Back to Search Start Over

A consistent arrhythmogenic trait in Brugada syndrome cellular phenotype.

Authors :
Al Sayed, Zeina R.
Jouni, Mariam
Gourraud, Jean‐Baptiste
Belbachir, Nadjet
Barc, Julien
Girardeau, Aurore
Forest, Virginie
Derevier, Aude
Gaignerie, Anne
Chariau, Caroline
Cimarosti, Bastien
Canac, Robin
Olchesqui, Pierre
Charpentier, Eric
Schott, Jean‐Jacques
Redon, Richard
Baró, Isabelle
Probst, Vincent
Charpentier, Flavien
Loussouarn, Gildas
Source :
Clinical & Translational Medicine. Jun2021, Vol. 11 Issue 6, p1-7. 7p.
Publication Year :
2021

Abstract

Global cellular electrophysiological phenotype was then evaluated with action potential (AP) recordings, but no AP basal parameters specifically segregated BrS hiPSC-CMs, and spontaneous beating frequencies did not differ between all cell lines (Figure S4). Brugada syndrome (BrS) is an inherited arrhythmic disease predisposing to sudden cardiac death (SCD), characterized by a typical electrocardiogram pattern that includes a J point elevation with a coved type ST segment.1 BrS is a complex genetic disease in which ~20% of patients carry rare variants in I SCN5A i gene, whereas the others remain genetically unresolved.2 Despite this genetic complexity, we hypothesize that a common cellular phenotypic trait is at the root of this specific BrS ECG pattern. Importantly, the expression of I SCN5A i , the main BrS culprit gene identified to date,4 remained unchanged, excluding I SCN5A i expression levels as a hallmark for BrS hiPSC-CM phenotype. Early afterdepolarizations (EADs) were observed in 39-70% of all six BrS ventricular-like hiPSC-CMs versus only in 4% and 4.7% of Ctrl and non-BrS hiPSC-CMs, respectively (Figure 3B, Figure S5). [Extracted from the article]

Details

Language :
English
ISSN :
20011326
Volume :
11
Issue :
6
Database :
Academic Search Index
Journal :
Clinical & Translational Medicine
Publication Type :
Academic Journal
Accession number :
151158102
Full Text :
https://doi.org/10.1002/ctm2.413